Major parameters related to a poor outcome of human papillomavirus (HPV)-/p16-negative HNSCC are the presence of lymph node metastases and local or loco-regional recurrences, which are a reflection of potent therapy resistance in these malignancies [4]. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.